Compounds > 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol
Page last updated: 2024-08-21

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Meibomian Gland Dysfunction

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol has been researched along with Meibomian Gland Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Arici, C; Bahar-Tokman, H; Kutlubay, Z; Mergen, B; Ozturk-Bakar, Y; Sahin, A; Tokuc, E; Yildiz-Tas, A1

Trials

1 trial(s) available for 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Meibomian Gland Dysfunction

ArticleYear
Randomized double-blind trial of wipes containing terpinen-4-ol and hyaluronate versus baby shampoo in seborrheic blepharitis patients.
    Eye (London, England), 2022, Volume: 36, Issue:4

    Topics: Blepharitis; Double-Blind Method; Eyelids; Glycosaminoglycans; Humans; Meibomian Gland Dysfunction; Tears; Terpenes

2022